Having established that enhanced PE systems can efficiently correct CFTR F508del and restore CFTR function in primary CF airway epithelial cells, we sought to characterize unintended editing outcomes of our PE strategy—including epegRNA scaffold integration, partial silent edit incorporation and genomic off-target editing—in detail. The gene discussed is CFTR; the disease is cystic fibrosis.